NASDAQ:QTNT Quotient (QTNT) Stock Price, News & Analysis → Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector… (From InvestorPlace) (Ad) Free QTNT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.19▼$0.8052-Week Range N/AVolume5.81 million shsAverage Volume437,886 shsMarket Capitalization$980,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Quotient alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Quotient Stock (NASDAQ:QTNT)Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. QTNT Stock News HeadlinesSeptember 5, 2023 | fool.comQuotient (NASDAQ: QTNT)November 16, 2022 | finance.yahoo.comQuotient Second Quarter 2023 Earnings: Revenues Miss ExpectationsNovember 2, 2022 | finance.yahoo.comQuotient Limited Announces Reverse Stock Split Effective TodayOctober 20, 2022 | techcrunch.comGlobalFair secures new cash to simplify procuring construction materials - TechCrunchOctober 19, 2022 | forbes.comTransforming Uncertainty Into Possibility - ForbesOctober 18, 2022 | benzinga.comQuotient Sciences Completes Major Expansion of Drug Substance Manufacturing Facility - BenzingaOctober 15, 2022 | finance.yahoo.comH.I.G. Acquisition Corp. Announces Redemption of Class A Ordinary Shares - Yahoo FinanceSeptember 29, 2022 | prnewswire.comOxilio and Quotient Sciences Announce Regulatory Approval for Oxilio's OXL001 Development Program - PR NewswireSeptember 28, 2022 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional US$231k as Quotient Limited (NASDAQ:QTNT) drops to US$20m - Yahoo FinanceSeptember 28, 2022 | businesswire.comQuotient's Omnichannel Measurement Now Combines Promotions with Media to Ensure Every Shoppable Moment is Attributable - Business WireSeptember 28, 2022 | finance.yahoo.comInsiders who bought in the last 12 months lose an additional US$231k as Quotient Limited (NASDAQ:QTNT) drops to US$20mSeptember 26, 2022 | bizjournals.comWhat are the most unique jobs in Buffalo, New York? - Buffalo Business First - The Business JournalsSeptember 23, 2022 | washingtonpost.com‘Catherine Called Birdy’: Lena Dunham's Y.A. take on the patriarchy - The Washington PostSeptember 22, 2022 | prnewswire.comQuotient Sciences Expands UK Facilities to Support the Delivery of Translational Pharmaceutics® Programs - PR NewswireSeptember 19, 2022 | washingtonpost.comBritish royal family has inspired souvenir collectors for decades - The Washington PostSeptember 12, 2022 | bizjournals.comThese are the 33 highest-paying jobs in the Buffalo metro area - Buffalo Business First - The Business JournalsSeptember 9, 2022 | benzinga.comThinking about buying stock in Nio, Quotient, Mogu, Rivian Automotive, or LYFT?September 9, 2022 | finance.yahoo.comThe Best (and Worst) Cities for People Without a College Degree - Yahoo FinanceSeptember 8, 2022 | globenewswire.comQuotient Limited Selected to Join the World Economic Forum New Champions Community - GlobeNewswireSeptember 8, 2022 | finance.yahoo.comQuotient Limited Selected to Join the World Economic Forum New Champions CommunitySeptember 7, 2022 | gurufocus.comUsing the Rule of 40 to Find Growth Opportunities - GuruFocus.comSeptember 7, 2022 | benzinga.comMIDWEST ENERGY EM (MEEC), Quotient Ltd (QTNT) – Quotient And 2 Other Stocks Under $1 Insiders Are Buying - BenzingaSeptember 1, 2022 | bizjournals.comThe key to success is AQ. Does your organization have it? - The Business JournalsAugust 31, 2022 | washingtonpost.comOpinion | Here's why the Trump GOP's crazy quotient is expanding - The Washington PostAugust 31, 2022 | benzinga.comHCW Biologics Inc (HCWB), Quotient Technology (QUOT) – Smith Micro Software And 3 Other Stocks Under $3 I - BenzingaSee More Headlines Receive QTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quotient and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/05/2021Today6/03/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:QTNT CUSIPN/A CIK1596946 Webwww.quotientbd.com Phone(122) 716-9800FaxN/AEmployees426Year Founded2008Profitability EPS (Most Recent Fiscal Year)($53.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-125,130,000.00 Net Margins-413.55% Pretax Margin-411.03% Return on EquityN/A Return on Assets-88.21% Debt Debt-to-Equity RatioN/A Current Ratio1.79 Quick Ratio1.36 Sales & Book Value Annual Sales$38.51 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($56.17) per share Price / BookN/AMiscellaneous Outstanding Shares2,580,000Free Float2,309,000Market Cap$980,000.00 OptionableOptionable Beta2.32 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Manuel O. Mendez (Age 54)CEO & Director Comp: $10.22MMr. Ali Kiboro (Age 47)Chief Financial Officer Comp: $798.9kMr. Mohammad El Khoury (Age 62)Chief Commercial Officer Comp: $544.83kMs. Vittoria Bonasso (Age 46)Head of Fin., Group Controller & Principal Accounting Officer Dr. Michael HausmannChief Technology OfficerDr. Christine GinocchioChief Scientific & Medical OfficerMs. Viviane MontarnalHead of Legal Affairs & ComplianceMs. Hyatt Antognini-AminHead of Corp. CommunicationsMr. Christian Albrich (Age 58)Chief People Officer Mr. Esteban UriarteChief Manufacturing Operations OfficerMore ExecutivesKey CompetitorsVirax Biolabs GroupNASDAQ:VRAXNavidea BiopharmaceuticalsNYSE:NAVBOxford Immunotec GlobalNASDAQ:OXFDHeskaNASDAQ:HSKAMeridian BioscienceNASDAQ:VIVOView All Competitors QTNT Stock Analysis - Frequently Asked Questions How were Quotient's earnings last quarter? Quotient Limited (NASDAQ:QTNT) posted its quarterly earnings data on Thursday, August, 5th. The company reported ($9.60) EPS for the quarter, beating analysts' consensus estimates of ($10.40) by $0.80. The firm had revenue of $9.09 million for the quarter, compared to analysts' expectations of $9.10 million. When did Quotient's stock split? Quotient shares reverse split on Thursday, November 3rd 2022. The 1-40 reverse split was announced on Thursday, November 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What other stocks do shareholders of Quotient own? Based on aggregate information from My MarketBeat watchlists, some companies that other Quotient investors own include VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Verastem (VSTM), Cidara Therapeutics (CDTX), Dynavax Technologies (DVAX), Gilead Sciences (GILD), SCYNEXIS (SCYX), Novavax (NVAX), Ocular Therapeutix (OCUL) and Sorrento Therapeutics (SRNE). This page (NASDAQ:QTNT) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersWho are Nvidia’s Silent Partners?Weiss RatingsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceThe Only Energy Play You Should Be Looking AtWealthpin Pro[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyCollapse of the Petrodollar Colonial Metals[Webinar] Understanding Covered CallsOICWhat’s Pelosi Buying Now?Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quotient Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.